Dianthus Therapeutics (DNTH) Other Gross PP&E Adjustments (2017 - 2025)
Dianthus Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$737000.0 in Q4 2025, up 92.86% year-on-year from -$382149.5 in Q4 2024, and up 12.68% quarter-over-quarter from -$844000.0 in Q3 2025.
Dianthus Therapeutics has reported Other Gross PP&E Adjustments for 9 years, with the latest figure at -$737000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 92.86% year-over-year to -$737000.0; the trailing twelve-month figure through Dec 2025 stood at -$737000.0 (up 92.86% YoY), and the FY2025 full-year result was -$737000.0, up 92.86% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$737000.0, up from -$844000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $8.7 million in Q4 2021, with the low at -$25.4 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$5.3 million, with a median of -$921000.0 recorded in 2025.
- Year-over-year, Other Gross PP&E Adjustments jumped 100.94% in 2024 and slumped 21200.0% in 2025.
- Tracing DNTH's Other Gross PP&E Adjustments over 5 years: stood at $8.7 million in 2021, then tumbled by 110.52% to -$915000.0 in 2022, then slumped by 642.62% to -$6.8 million in 2023, then tumbled by 51.83% to -$10.3 million in 2024, then jumped by 92.86% to -$737000.0 in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$737000.0 (Q4 2025), -$844000.0 (Q3 2025), and -$921000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | -737,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -737,000.00 |
| Dec 31, 2025 | -737,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Mar 31, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -10.32 Mn |
| Dec 31, 2024 | -10.32 Mn |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | -111,000.00 |
| Jun 30, 2024 | -111,000.00 |
| Mar 31, 2024 | -216,000.00 |
| Mar 31, 2024 | -216,000.00 |
| Dec 31, 2023 | -6.80 Mn |
| Dec 31, 2023 | -6.80 Mn |
| Sep 30, 2023 | -426,000.00 |
| Sep 30, 2023 | -426,000.00 |
| Jun 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -1.32 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Dec 31, 2022 | -915,000.00 |
| Dec 31, 2022 | -915,000.00 |
| Sep 30, 2022 | -23.93 Mn |
| Sep 30, 2022 | -23.93 Mn |
| Jun 30, 2022 | -24.67 Mn |
| Jun 30, 2022 | -24.67 Mn |
| Mar 31, 2022 | -25.39 Mn |
| Mar 31, 2022 | -25.39 Mn |
| Dec 31, 2021 | 8.70 Mn |
| Dec 31, 2021 | 8.70 Mn |
| Dec 31, 2020 | 10.39 Mn |
| Dec 31, 2020 | 10.39 Mn |
| Dec 31, 2019 | 10.70 Mn |
| Dec 31, 2019 | 10.70 Mn |
| Dec 31, 2018 | 9.97 Mn |
| Dec 31, 2018 | 9.97 Mn |
| Dec 31, 2017 | 2.33 Mn |
| Dec 31, 2017 | 2.33 Mn |